DOI:
10.1055/s-00000099
Zeitschrift für Orthopädie und Unfallchirurgie
LinksClose Window
References
Cadavid D, Mellion M, Hupperts R. et al.
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial.
Lancet Neurol 2019;
DOI: 10.1016/S1474-4422(19)30137-1.
We do not assume any responsibility for the contents of the web pages of other providers.